Rao et al. studied 18 HD patients under erythropoietin (EPO)treatment and observed a trend for poor EPO-response in those with high depositionof Al in osteoid surfaces.17 The accumulationof this metal in bone tissue causes osteomalacia and adynamic bone disease. This evidence concerns the gene EPO and osteomalacia.